1095 related articles for article (PubMed ID: 22037378)
1. Comprehensive analysis of kinase inhibitor selectivity.
Davis MI; Hunt JP; Herrgard S; Ciceri P; Wodicka LM; Pallares G; Hocker M; Treiber DK; Zarrinkar PP
Nat Biotechnol; 2011 Oct; 29(11):1046-51. PubMed ID: 22037378
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity.
Anastassiadis T; Deacon SW; Devarajan K; Ma H; Peterson JR
Nat Biotechnol; 2011 Oct; 29(11):1039-45. PubMed ID: 22037377
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in designing substrate-competitive protein kinase inhibitors.
Han KC; Kim SY; Yang EG
Curr Pharm Des; 2012; 18(20):2875-82. PubMed ID: 22571656
[TBL] [Abstract][Full Text] [Related]
4. Large-scale proteomics analysis of the human kinome.
Oppermann FS; Gnad F; Olsen JV; Hornberger R; Greff Z; Kéri G; Mann M; Daub H
Mol Cell Proteomics; 2009 Jul; 8(7):1751-64. PubMed ID: 19369195
[TBL] [Abstract][Full Text] [Related]
5. Cross-reactivity virtual profiling of the human kinome by X-react(KIN): a chemical systems biology approach.
Brylinski M; Skolnick J
Mol Pharm; 2010 Dec; 7(6):2324-33. PubMed ID: 20958088
[TBL] [Abstract][Full Text] [Related]
6. Unprecedently Large-Scale Kinase Inhibitor Set Enabling the Accurate Prediction of Compound-Kinase Activities: A Way toward Selective Promiscuity by Design?
Christmann-Franck S; van Westen GJ; Papadatos G; Beltran Escudie F; Roberts A; Overington JP; Domine D
J Chem Inf Model; 2016 Sep; 56(9):1654-75. PubMed ID: 27482722
[TBL] [Abstract][Full Text] [Related]
7. Current compound coverage of the kinome.
Hu Y; Furtmann N; Bajorath J
J Med Chem; 2015 Jan; 58(1):30-40. PubMed ID: 25051177
[TBL] [Abstract][Full Text] [Related]
8. Interrogating the kinome.
Zhang C; Habets G; Bollag G
Nat Biotechnol; 2011 Nov; 29(11):981-3. PubMed ID: 22068532
[No Abstract] [Full Text] [Related]
9. Quantitative proteomics of kinase inhibitor targets and mechanisms.
Daub H
ACS Chem Biol; 2015 Jan; 10(1):201-12. PubMed ID: 25474541
[TBL] [Abstract][Full Text] [Related]
10. Conformation-Selective Analogues of Dasatinib Reveal Insight into Kinase Inhibitor Binding and Selectivity.
Kwarcinski FE; Brandvold KR; Phadke S; Beleh OM; Johnson TK; Meagher JL; Seeliger MA; Stuckey JA; Soellner MB
ACS Chem Biol; 2016 May; 11(5):1296-304. PubMed ID: 26895387
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive structural and functional characterization of the human kinome by protein structure modeling and ligand virtual screening.
Brylinski M; Skolnick J
J Chem Inf Model; 2010 Oct; 50(10):1839-54. PubMed ID: 20853887
[TBL] [Abstract][Full Text] [Related]
12. The human kinome and kinase inhibition.
Duong-Ly KC; Peterson JR
Curr Protoc Pharmacol; 2013 Mar; Chapter 2():Unit2.9. PubMed ID: 23456613
[TBL] [Abstract][Full Text] [Related]
13. Extending kinome coverage by analysis of kinase inhibitor broad profiling data.
Jacoby E; Tresadern G; Bembenek S; Wroblowski B; Buyck C; Neefs JM; Rassokhin D; Poncelet A; Hunt J; van Vlijmen H
Drug Discov Today; 2015 Jun; 20(6):652-8. PubMed ID: 25596550
[TBL] [Abstract][Full Text] [Related]
14. Computational proteomics of biomolecular interactions in the sequence and structure space of the tyrosine kinome: deciphering the molecular basis of the kinase inhibitors selectivity.
Verkhivker GM
Proteins; 2007 Mar; 66(4):912-29. PubMed ID: 17173284
[TBL] [Abstract][Full Text] [Related]
15. Rational creation and systematic analysis of cervical cancer kinase-inhibitor binding profile.
Han M; Sun D
J Comput Aided Mol Des; 2019 Jul; 33(7):689-698. PubMed ID: 31203490
[TBL] [Abstract][Full Text] [Related]
16. Prediction of specificity-determining residues for small-molecule kinase inhibitors.
Caffrey DR; Lunney EA; Moshinsky DJ
BMC Bioinformatics; 2008 Nov; 9():491. PubMed ID: 19032760
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of kinase-selective inhibitors by chemical proteomics.
Daub H
Biochim Biophys Acta; 2005 Dec; 1754(1-2):183-90. PubMed ID: 16198161
[TBL] [Abstract][Full Text] [Related]
18. Unexpected off-targets and paradoxical pathway activation by kinase inhibitors.
Hantschel O
ACS Chem Biol; 2015 Jan; 10(1):234-45. PubMed ID: 25531586
[TBL] [Abstract][Full Text] [Related]
19. Bioluminescent kinase strips: A novel approach to targeted and flexible kinase inhibitor profiling.
Hennek J; Alves J; Yao E; Goueli SA; Zegzouti H
Anal Biochem; 2016 Feb; 495():9-20. PubMed ID: 26628096
[TBL] [Abstract][Full Text] [Related]
20. Tinkering outside the kinase ATP box: allosteric (type IV) and bivalent (type V) inhibitors of protein kinases.
Cox KJ; Shomin CD; Ghosh I
Future Med Chem; 2011 Jan; 3(1):29-43. PubMed ID: 21428824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
